Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Blocking cancer in its path: New cellular defect discovered
Slashdot It! Slashdot Blocking cancer in its path: New cellular defect discovered
Submit to Reddit Submit Blocking cancer in its path: New cellular defect discovered to Reddit
Add to Facebook Add Blocking cancer in its path: New cellular defect discovered to Facebook

Blocking cancer in its path: New cellular defect discovered

March 17, 2010

UCSF researchers have discovered that a key cellular defect that disturbs the production of proteins in human cells can lead to cancer susceptibility. The scientists also found that a new generation of inhibitory drugs offers promise in correcting this defect.

According to the study team, this discovery has broad clinical implications in the fight against cancer and could affect treatment of lymphoma and many other forms of the disease, including prostate cancer, breast cancer, colorectal cancer, brain cancer and multiple myeloma.




The findings are featured as the cover story in the March 16, 2010 issue of the scientific journal Cancer Cell (http://www.cell.com/cancer-cell/issue?pii=S1535-6108%2810%29X0004-6).

The discovery was made in the laboratory of UCSF faculty scientist Davide Ruggero, PhD, whose lab team is doing research in the burgeoning field of study on how defects in protein synthesis can lead to cancer susceptibility.

"Our work has the potential to create real, tangible benefits for the medical community," said Ruggero, an assistant professor of urology at the UCSF Helen Diller Family Comprehensive Cancer Center and senior author of the paper.

The researchers focused on a multi-protein unit known as mTOR, which stands for the "mammalian target of rapamycin." mTOR controls several important processes in mammalian cells, including cell survival and proliferation.

One of the most significant of these processes is the production of proteins within a cell, the control of which is known as translational control. mTOR integrates information about the cell's nutritional and energy needs, and prompts the cell to manufacture key proteins for cell growth. Cancer cells exploit this signal for their own growth.

According to the researchers, when the cells in the body lose the ability to control mTOR activity, mTOR is considered "hyperactivated." This hyperactivation causes protein synthesis rates to climb. Cells begin to proliferate without limits and simultaneously become immortal, all of which leads to tumor formation.

"Our findings show that for a cancer cell, normal cellular functions such as protein synthesis can be specifically hijacked for tumor growth," explained first author Andrew Hsieh, a clinical fellow at the UCSF School of Medicine and the Department of Urology at the Helen Diller Family Comprehensive Cancer Center.

Ruggero said that the "dismal" clinical results seen with first generation mTOR inhibitor drugs like rapamycin "stemmed in part from the inadequate limit on unhealthy protein synthesis that is caused by hyperactivated mTOR."

Researchers in his laboratory made this key discovery through genetic tests that demonstrate that healthy genes in charge of protein production can become cancerous when mTOR is hyperactivated. To combat this, the scientists employed a new drug called PP242. This drug was discovered at UCSF in the lab of Kevan Shokat, PhD, Howard Hughes Medical Investigator and professor of cellular and molecular pharmacology at UCSF.

"This drug has shown promising results by bringing protein synthesis and cell proliferation levels back down to normal rates," Ruggero said. "In addition, PP242 helps fight the process of immortalization that cancer cells go through."

In their findings, PP242 proved to be more effective than similar drugs in its ability to jumpstart translational control in both live mice and human cells tested in the lab. PP242 is currently in Phase 1 clinical trials.

"We demonstrated that the drug kills the cancer cells more effectively because it blocks the abnormal production of proteins," said Ruggero. "The other drugs we tested did not show clinical effectiveness in blocking cancer development in this manner.''

The authors say that PP242 could become a potent cancer treatment. The findings are a positive step, Ruggero said, because what have previously been considered unresponsive tumors can now be treated with the second generation of inhibitors that halt mTOR's action on protein production.

"We are extremely excited about our findings and the potential of targeting aberrant protein synthesis and mTOR in cancer as we should be able to block cancer's main source of growth," said Ruggero. "We are working with clinicians to test our hypothesis in a variety of human tumors."

Co-authors working in Ruggero's lab during the research project include clinical fellow Cole Davis, PhD, as well as post-doctoral fellows Maria Costa, PhD, and Ornella Zollo, PhD. Zollo is funded by the American-Italian Cancer Foundation. Ruggero's UCSF collaborators and co-authors also include Shokat, who develops chemical methods to decipher the role of individual kinases and their cellular signaling networks, and his post-doctoral fellow, Morris Feldman, PhD.

Ruggero's outside collaborators were Joseph Testa, PhD, co-director of the Fox Chase Cancer Biology Program, and Oded Meyuhas, PhD, head of the Department of Biochemistry at the Hebrew University in Jerusalem.

The research was funded by the National Institutes of Health. Ruggero is a Leukemia & Lymphoma Society Scholar.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.

The University of California, San Francisco




Related Protein Synthesis Current Events and Protein Synthesis News Articles Protein Synthesis Current Events and Protein Synthesis News RSS Protein Synthesis Current Events and Protein Synthesis News RSS
Native-like spider silk produced in metabolically engineered bacterium
Researchers have long envied spiders' ability to manufacture silk that is light-weighted while as strong and tough as steel or Kevlar.

Genetic Code 2.0
The creation of synthetic proteins plays an important role for economy and science. By the integration of artificial amino acids in proteins (genetic code engineering), their already existing qualities can be systematically improved, allowing new biological features to arise.

In elevated carbon dioxide, soybeans stumble but cheatgrass keeps on truckin'
In August of 2008 Jacob Schaefer, PhD, on vacation in San Diego, picked up a copy of the Los Angeles Times. As it happened, the newspaper was running a series on the wildfires in the western United States.

Chocolate milk is a 'natural' for post-exercise recovery
One of the best post-exercise recovery drinks could already be in your refrigerator, according to new research presented at the American College of Sports Medicine conference this week.

Muscle loss in elderly linked to blood vessels' failure to dilate
Why do people become physically weaker as they age? And is there any way to slow, stop, or even reverse this process, breaking the link between increasing age and frailty?

Muscle mass in elderly boosted by combining resistance exercise and blood flow restriction
For years, researchers have known that resistance exercise training -such as weightlifting, in which muscles work against gravity or another force - can be one of the most effective ways to fight the debilitating muscle loss caused by aging.

Mild-mannered metabolic helper rushes to fight invading viruses, researchers report
Within cells, an ancient antiviral duo can deliver a one-two knockout to thwart invading viruses, report researchers who have just unmasked the cellular sidekick that throws the first punch. The findings mean scientists must rethink the design of antiviral immunity and how the body fends off viruses of all types, including influenza and HIV.

Putting bacterial antibiotic resistance into reverse
The use of antibiotics to treat bacterial infections causes a continual and vicious cycle in which antibiotic treatment leads to the emergence and spread of resistant strains, forcing the use of additional drugs leading to further multi-drug resistance.

New understanding of protein's role in brain
How do we process thoughts and store memories? A team of researchers headed by Dr. Nahum Sonenberg of McGill's Department of Biochemistry and Goodman Cancer Centre has discovered that brains in mammals modify a particular protein in a unique way, which alters the protein's normal function.

Neuroimaging study describes Alzheimer's disease-like changes in elderly people without the disease
The emergence of multiple new brain imaging technologies and the combined application of these new approaches is helping to create new insights into aging and Alzheimer's disease.
More Protein Synthesis Current Events and Protein Synthesis News Articles
Chemical Approaches to the Synthesis of Peptides and Proteins (New Directions in Organic & Biological Chemistry)

Chemical Approaches to the Synthesis of Peptides and Proteins (New Directions in Organic & Biological Chemistry)
by Paul Lloyd-Williams (Author), Fernando Albericio (Author), Ernest Giralt (Author)

Organic chemists working on the synthesis of natural products have long found a special challenge in the preparation of peptides and proteins. However, more reliable, more efficient synthetic preparation methods have been developed in recent years. This reference evaluates the most important synthesis methods available today, and also considers methods that show promise for future applications.This text describes the state of the art in efficient synthetic methods for the synthesis of both natural and artificial large peptide and protein molecules. Subjects include an introduction to basic topics, linear solid-phase synthesis of peptides, peptide synthesis in solution, convergent solid-phase synthesis, methods for the synthesis of branched peptides, formation of disulfide bridges, and...

Protein for Exercise and Recovery

Protein for Exercise and Recovery

Abstract: Dietary protein is required to promote growth, repair damaged cells and tissue, synthesize hormones, and for a variety of metabolic activities. There are multiple sources of proteins available; however, animal sources of protein contain all essential amino acids and are considered complete sources of protein, whereas plant proteins lack some of the essential amino acids and are therefore classified as incomplete. There is a significant body of evidence to indicate that individuals who are engaged in intense training require more dietary protein than sedentary counterparts (ie, 1.4–2 g/kg/day). For most individuals, this level of protein intake can be obtained from a regular and varied diet. However, recent evidence indicates that ingesting protein and/or amino acids prior to,...

Nx Labs, Aminovol, Protein Synthesis Stimulator, 240 caplets

Nx Labs, Aminovol, Protein Synthesis Stimulator, 240 caplets
by NxLABS, INC.

Nx Labs, Aminovol, Protein Synthesis Stimulator, 240 capletsDietary supplement. Anabolic/anti-catabolic formula. Rapid size & strength. Incredible muscle pumps. Prevent muscle breakdown. Pharmaceutical quality. Aminovol’s revolutionary formula contains 10 complexes designed to increase protein synthesis, nitric oxide, lean muscle mass and strength when combined with intense training and proper nutrition. Aminovol’s time release formula delivers a sustained release of key amino acids to keep your muscles anabolic and anticatabolic all day long. It is the most powerful amino acid supplement on the market. (These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.) Product of...

SciEd Protein Synthesis Manipulative Kit

SciEd Protein Synthesis Manipulative Kit
by United Scientific Supplies

Kit, Educational; Protein Synthesis Manipulative Kit; DNA, mRNA, ribosome, tRNA and amino acid attach to the blackboard for a visual simulation of protein synthesis; Class size: 30 students

  Science in Action: The Atoms and Molecules of Line/DNA and Protein Synthesis
Also With: Rinehart and Winston Holt (Producer)



  Protein Synthesis Dna Replication: The Repeating Formula(vhs)
by Films for the humanities



Protein Synthesis Manipulatives Classroom Kit For Class of 30

Protein Synthesis Manipulatives Classroom Kit For Class of 30
by United Scientific Supplies Inc

Protein Synthesis Manipulatives Classroom KitDeveloped by teachers, this kit aids students in understanding the principles of Protein Synthesis Manipulatives.  Whether you have taught this content a thousand times or this is your first, you will find that all students can learn this material! What makes this kit different than any other kit is hands-on experience. This kit inlcudes Teacher Manipulatives, Student Manipulatives, and Assesments.  Materials for a class of 30 students working in groups of 6.Teacher Manipulatives: These colorful, large DNA, mRNA, Ribosome,tRNA and amino acid models attach to your black/whiteboard and can be seen from the back of the classroom.  You simulate the process for your students at your own pace, allowing students to ask questions as you...

Sound Effect - Alien Protein Synthesis

Sound Effect - Alien Protein Synthesis
City Of Prague Philharmonic (Primary Contributor)



Protein Expression Technologies: Current Status and Future Trends (Horizon Bioscience)

Protein Expression Technologies: Current Status and Future Trends (Horizon Bioscience)
by F. Baneyx (Author)

Univ. of Washington, Seattle. Comprehensively reviews molecular genetics of expression systems in various organisms. Covers expression of extremophilic proteins, expression in E. coli, cell expression and the baculovirus system, and more. For researchers in making educated choices on the technology best suited for their individual needs.

Journal of Biological Chemistry :: Protein Synthesis & Degrad.::

Journal of Biological Chemistry :: Protein Synthesis & Degrad.::
by American Society for Biochemistry and Molecular Biology

JBC Table of Contents Categories are now available as RSS feeds. Get weekly fresh updates of you TOC section of choice. The Journal of Biological Chemistry (JBC) is the most-cited biomedical research journal in the world. Building on over 100 years of research, the JBC continues to provide essential research for an international audience and a standard of excellence in the field of biochemistry.* Published Weekly, Over 38,000 Pages Annually* Papers of the Week Chosen for Superior Relevancy* "JBC News" Podcasts Spotlight Featured Articles and Include an Editorial Perspective* The "Classics" Highlight Important Articles from the JBC Archive* Minireviews Present Concise Summaries of Rapid Advances and Trends in BiochemistryKindle blogs are fully downloaded onto your Kindle so you can read...

© 2010 BrightSurf.com